Question 1

How many shares of AR2 does DRIEHAUS CAPITAL MANAGEMENT LLC own?

Accepted Answer

DRIEHAUS CAPITAL MANAGEMENT LLC previously held 0 shares of AR2 (ARRAY BIOPHARMA INC) before exiting the position in 2019-Q3.

Question 2

What is DRIEHAUS CAPITAL MANAGEMENT LLC's AR2 position worth?

Accepted Answer

DRIEHAUS CAPITAL MANAGEMENT LLC's AR2 position was last reported at $0 in 2019-Q3 before the exit.

Question 3

Is DRIEHAUS CAPITAL MANAGEMENT LLC buying or selling AR2?

Accepted Answer

In 2019-Q3, DRIEHAUS CAPITAL MANAGEMENT LLC exited their AR2 position entirely (-100.0% change in shares).

Question 4

When did DRIEHAUS CAPITAL MANAGEMENT LLC first buy AR2?

Accepted Answer

Based on available 13F filings, DRIEHAUS CAPITAL MANAGEMENT LLC first reported a position in AR2 in 2019-Q1. They have held the position across 3 quarters.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2019-Q3 Latest	Exited	0	-100.0%	$0	0.0%	—	0
2019-Q2	Decreased	432,003	-76.1%	$20M	0.6%	—	0
2019-Q1	New	1.8M	-	$44.1M	1.7%	—	67

AR23 quarters

AR2
3 quarters